Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi A look into Possible New Treatment Modality for COVID 19: ACE 2
*Corresponding Author: Mayank Kapoor, Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Rishikesh, India, Email: mkapoorsonu@yahoo.co.inReceived Date: Apr 30, 2020 / Accepted Date: May 09, 2020 / Published Date: May 18, 2020
Citation: Kapoor M, Dhar M (2020) A Look into Possible New Treatment Modality For COVID–19: ACE 2. J Infect Dis Ther 8: 425.
Copyright: © 2020 Kapoor M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Many articles about COVID 19 have mentioned various experimental drugs but nowhere it has been mentioned about any new research on ACE 2 (Angiotensin converting enzyme 2), which is a receptor for coronavirus, in the direction of curbing it. Hereby a logically deduced & scientific study backed analysis of a group of drugs affecting the ACE2 system is presented. ACE2 is an integral part of the pathogenic mechanisms & disease progression of COVID-19 & up regulation of ACE2 levels leads to significant reduction in morbidity & mortality of ARDS. SARSCoV- 2 binds to & down regulates this protective ACE2 & thus leads to the acute lung injury associated with it. Hence ACE 2 up regulation maybe the way to defeat this pandemic which has the whole of humanity in its grip.
